Global Cell Therapy Technologies Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Cell Therapy Technologies Industry Market Size Be by 2025?
The sphere of cell therapy technologies has experienced a swift expansion lately, projecting a move from its 2024 valuation of $4.92 billion to $5.67 billion by 2025, reflecting a compound annual growth rate (CAGR) calculation of 15.4%. This upward trajectory observed during the past period stems from robust economic expansion taking place in developing regions, augmented spending on healthcare services, heightened governmental funding directed toward research involving cells, and a continuously rising requirement for treatments tailored to the individual patient.

What's the Long-Term Growth Forecast for the Cell Therapy Technologies Market Size Through 2029?
Forecasting significant expansion, the market encompassing cell therapy technologies anticipates swift upswing in the coming years, projected to reach nine point eight seven billion dollars by 2029, driven by a compound annual growth rate (CAGR) of fourteen point nine percent; this prospective surge is fueled by several factors, notably the expanding elderly demographic, the mounting incidence of malignant growths, heightened expenditures on research and development within the pharmaceutical industry, and continuous progress in the field of cellular therapeutic methods, while key directional shifts observed during this projection window involve the creation of novel solutions, the adoption of sophisticated technological applications, the innovation in cell-based treatments, capital infusion into production infrastructure, and the forging of strategic alliances and cooperative agreements.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

What Are the Key Growth Drivers Fueling the Cell Therapy Technologies Market Expansion?
Elevated governmental funding allocated towards cell-based investigations has been a key factor in the expansion of the worldwide market for cell therapy technologies, as nations are channeling greater resources into research aimed at pioneering treatments for ailments like malignant tumors and cardiovascular conditions. To illustrate this trend, the California Institute for Regenerative Medicine (CIRM), a hub supporting stem cell studies, injected over $11 million in May 2022 to back a clinical trial testing a cell therapy designed to combat laryngeal cancer, which, if proven effective, could spare patients from enduring radiation treatment along with its associated adverse effects.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

What Are the Key Trends Driving Cell Therapy Technologies Market Growth?
Leading corporations within the cell therapy technologies sector are actively innovating their offerings through the application of sophisticated technologies, aiming for expanded market presence. As an illustration, in mid-2022, Invetech, an Australian firm known for designing, engineering, and producing large-scale diagnostic products alongside cell and gene therapies, introduced Korus, which is a novel, fully contained apparatus intended for autologous cell therapies, designed to revolutionize established industry benchmarks for both cell washing and elutriation techniques. This technology employs a gentle elutriation mechanism, resulting in a more refined cell quantity suitable for various cell therapy manufacturing workflows, including therapies involving tumor-infiltrated lymphocytes (TIL), dendritic cells, chimeric antigen receptor (CAR)-T cells, or those derived from induced pluripotent stem cells (IPSC). Inherent to its design are cell wash and elutriation capabilities relying on mild counterflow centrifugation, which delivers purified cell concentrates essential for the subsequent stages of development and volume manufacturing. Implementation of this new Korus platform is anticipated to boost process efficiency overall by achieving superior levels of both recovery and purity for the intended cell types, consequently enabling developers to accelerate the progression through clinical trials and the subsequent scale-up of their therapeutic agents.

How Is the Cell Therapy Technologies Market Segmented?
The cell therapy technologiesmarket covered in this report is segmented -

1) By Product: Consumables, Equipment, Systems And Software
2) By Cell Type: T-Cells, Stem Cells, Other Cells
3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control
4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:
1) By Consumables: Cell Culture Media; Bioreactors And Cell Culture Vessels; Cell Separation And Processing Kits; Cryopreservation Bags And Vials
2) By Equipment: Cell Counters; Centrifuges; Cell Sorting Equipment; Incubators
3) By Systems And Software: Closed-System Cell Processing Systems; Automated Cell Culture Systems; Point-Of-Care Cell Therapy Systems; Laboratory Information Management Systems (LIMS); Data Management Software For Cell Therapies; Process Optimization And Tracking Software

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=4122&type=smp

Which Companies Are Leading the Charge in Cell Therapy Technologies Market Innovation?
Major companies operating in the cell therapy technologies market include Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Holdings Corporation, Sartorius AG, Becton dic*kinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Huadong Medicine, Co.Don AG, AstraZeneca, Neogene Therapeutics, GammaDelta Therapeutics Limited, Nightstar, SOTIO, Accell Clinical Research, Genestack, Novartis AG, Pfizer, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Bayer AG, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Amgen Brazil, GlaxoSmithKline plc, Biogen Brazil, Takeda Pharmaceutical Company Limited, Pfizer S.R.L, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Bayer East Africa Ltd, Adcock Ingram, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies.

Which Regions Are Leading the Global Cell Therapy Technologies Market in Revenue?
North America was the largest region in the cell therapy technologies market in 2024. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4122

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.